Lactate-to-Albumin Ratio as a Prognostic Biomarker in Sepsis: Current Evidence  and Future Direction

Shimaa Morsy Mohamed , Fayruoz Othman Selim , Ahmed Abdelwhab Ali Ahmed , Nahawand A. El-Deeb

Lactate-to-Albumin Ratio as a Prognostic Biomarker in Sepsis: Current Evidence and Future Direction

Authors

Shimaa Morsy Mohamed , Fayruoz Othman Selim , Ahmed Abdelwhab Ali Ahmed , Nahawand A. El-Deeb

Keywords:

Lactate-to-Albumin Ratio, Prognostic Biomarker,Sepsis

Abstract

Background: Sepsis remains a leading cause of morbidity and mortality in critically ill patients, despite advancesin antimicrobial therapy, supportive care, and early recognition protocols. Traditional biomarkers such as lactatehave been central to risk stratification

References

Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 19902017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200-211.

Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286(14):1754-1758.

Downloads

Published

2024-06-20

How to Cite

Shimaa Morsy Mohamed , Fayruoz Othman Selim , Ahmed Abdelwhab Ali Ahmed , Nahawand A. El-Deeb. (2024). Lactate-to-Albumin Ratio as a Prognostic Biomarker in Sepsis: Current Evidence and Future Direction. Journal of Computational Analysis and Applications (JoCAAA), 33(06), 2903–2912. Retrieved from https://www.eudoxuspress.com/index.php/pub/article/view/3729